Nothing said here yet.
to join the conversation.
Ariel Investments, an investment management company, released its “Ariel Focus Fund” Q3 2026 investor letter. A copy of the letter can be downloaded here.
XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.
Dentsply Sirona has gotten torched over the last six months - since April 2026, its stock price has dropped 27.3% to $8.62 per share. This may have investors wondering how to approach the situation.
Why the Midwest Dental expansion matters for DENTSPLY SIRONA DENTSPLY SIRONA (XRAY) has extended its relationship with Midwest Dental, which will start distributing the company’s technology portfolio across the United States from 1 November 2026.
The global dental implants and prosthetics market is projected to grow from USD 12.79 billion in 2026 to USD 17.67 billion by 2031, at a 6.7% CAGR.
The global dental equipment market is projected to grow from USD 8.31 billion in 2026 to USD 11.48 billion by 2031, registering a 5.5% CAGR.
The global dental consumables market is projected to grow from USD 37.0 billion in 2026 to USD 54.0 billion by 2031, registering a 7.9% CAGR.
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & technology stocks fared in Q2, starting with Dentsply Sirona (NASDAQ:XRAY).
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.